Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : CEP 2011-120 - Rev 05
Status : Valid
Issue Date : 2024-04-17
Type : Chemical
Substance Number : 2013
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Ciprofibrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ciprofibrate manufacturer or Ciprofibrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ciprofibrate manufacturer or Ciprofibrate supplier.
PharmaCompass also assists you with knowing the Ciprofibrate API Price utilized in the formulation of products. Ciprofibrate API Price is not always fixed or binding as the Ciprofibrate Price is obtained through a variety of data sources. The Ciprofibrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hiperlipen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hiperlipen, including repackagers and relabelers. The FDA regulates Hiperlipen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hiperlipen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hiperlipen manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hiperlipen supplier is an individual or a company that provides Hiperlipen active pharmaceutical ingredient (API) or Hiperlipen finished formulations upon request. The Hiperlipen suppliers may include Hiperlipen API manufacturers, exporters, distributors and traders.
click here to find a list of Hiperlipen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hiperlipen CEP of the European Pharmacopoeia monograph is often referred to as a Hiperlipen Certificate of Suitability (COS). The purpose of a Hiperlipen CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hiperlipen EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hiperlipen to their clients by showing that a Hiperlipen CEP has been issued for it. The manufacturer submits a Hiperlipen CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hiperlipen CEP holder for the record. Additionally, the data presented in the Hiperlipen CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hiperlipen DMF.
A Hiperlipen CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hiperlipen CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Hiperlipen suppliers with CEP (COS) on PharmaCompass.
A Hiperlipen written confirmation (Hiperlipen WC) is an official document issued by a regulatory agency to a Hiperlipen manufacturer, verifying that the manufacturing facility of a Hiperlipen active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Hiperlipen APIs or Hiperlipen finished pharmaceutical products to another nation, regulatory agencies frequently require a Hiperlipen WC (written confirmation) as part of the regulatory process.
click here to find a list of Hiperlipen suppliers with Written Confirmation (WC) on PharmaCompass.
Hiperlipen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hiperlipen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hiperlipen GMP manufacturer or Hiperlipen GMP API supplier for your needs.
A Hiperlipen CoA (Certificate of Analysis) is a formal document that attests to Hiperlipen's compliance with Hiperlipen specifications and serves as a tool for batch-level quality control.
Hiperlipen CoA mostly includes findings from lab analyses of a specific batch. For each Hiperlipen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hiperlipen may be tested according to a variety of international standards, such as European Pharmacopoeia (Hiperlipen EP), Hiperlipen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hiperlipen USP).
